| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Kozarich John W is a Director at LGND, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 57 sales. Those positions are worth an estimated $14.7M at current prices.
Our model assigns Kozarich John W a middling insider score of 55/100, based on 10 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -19.2%.
Kozarich John W's largest disclosed position is in LGND as Director, worth about $12.8M. The recent filings there lean toward selling, a net 46,328 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $117.42 | $117,419.00 | -1.1% | |
| May 2, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $121.57 | $121,568.00 | -1.1% | |
| Apr 6, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 5,000 | $115.00 | $575,000.00 | -10.1% | |
| Jan 20, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 1,666 | $94.94 | $158,173.34 | -0.7% |